5:39 PM
 | 
Apr 30, 2013
 |  BC Extra  |  Company News

FDA approves OTC Plan B for ages 15 and up

FDA approved an amended sNDA from Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) for Plan B One-Step levonorgestrel for use without a prescription by women ages 15 and older. The label for the emergency contraceptive, which...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >